More on LTGO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:LTGO)
Delayed: 16.00 +1.21 (8.18%)
Prev. Close $14.79  
Open$14.84 
52 Wk High$ 
52 Wk Low$ 
Day High$16.08 
Day Low$14.61 
P/E N/A  
EPS$ 
Volume184,215 


Sep 14, 2026 07:53 AM Goldman Sachs Reiterates Buy Rating on Latigo Biotherapeutics (LTGO)
Sep 3, 2026 04:05 PM Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Sep 1, 2026 06:16 AM Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
Sep 1, 2026 06:11 AM Leerink Starts Latigo Biotherapeutics (LTGO) at Outperform
Sep 1, 2026 03:38 AM Guggenheim Starts Latigo Biotherapeutics (LTGO) at Buy
Sep 1, 2026 02:49 AM Goldman Sachs Starts Latigo Biotherapeutics (LTGO) at Buy
Aug 6, 2026 08:03 PM Latigo Biotherapeutics prices $345.6M IPO at $18 per share
Aug 6, 2026 08:03 PM Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
Aug 4, 2026 06:09 AM Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share
Aug 3, 2026 07:51 AM Latigo Biotherapeutics seeks to raise up to $288m in IPO
View All Articles

Entities mentioned with LTGO

View All Entities